EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, ABSI: Absci Corp

23 Mar 26 15:59
LAST:

2.950

CHANGE:
 0.03		OPEN:
2.800		HIGH:
3.080		ASK:
0.000		VOLUME:
3.26M
CHG(%):
1.01		PREV:
2.960		LOW:
2.800		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
23 Mar 263.0003.0402.8602.9303.81M
20 Mar 263.0503.2002.9002.9608.38M
19 Mar 262.8003.1402.7903.0803.81M
18 Mar 262.9203.0702.8352.8606.83M
17 Mar 262.6103.0552.5603.03010.32M
16 Mar 262.4302.5302.4052.5002.42M
13 Mar 262.3202.4302.3102.3902.5M
12 Mar 262.4102.4302.2402.3003.22M
11 Mar 262.5002.5202.4002.4502.13M
10 Mar 262.5302.5852.4902.5402.09M

PROFILE

Name:Absci Corp
About:Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combines AI with scalable wet lab technologies to design differentiated antibody therapeutics. Its preclinical development programs include ABS-101 for the treatment of inflammatory bowel disease; ABS-201 for treating androgenic alopecia; ABS-301 for the treatment of immuno-oncology; and ABS-501 for treating oncology. Absci Corporation has collaboration agreements with PrecisionLife, Memorial Sloan Kettering Cancer Center, Twist Bioscience, Owkin, Oracle Corporation, and Advanced Micro Devices, Inc. for joint research and development activities. The company was founded in 2011 and is headquartered in Vancouver, Washington.
Sector:Healthcare
Industry:Biotechnology
Address:18105 SE Mill Plain Boulevard, Vancouver, WA, United States, 98683
Website:https://www.absci.com
CUSIP:00091E109
CIK:0001672688
ISIN:US00091E1091
FIGI:BBG011N54CJ8

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-4.37 
Forward P/E:-5.98 
PEG Ratio:-0.48 
Price to Sales:154.65 
Price to Book:2.86 
Operating Margin:-52.94 
Return on Assets:-0.31 
Return on Equity:-0.57 
EPS Ratio:-0.91 
Revenue:4.14M 
Shares:150.37M 
Market Cap:443.6M 

TECHNICAL INDICATORS

MA5:2.970.7%
MA10:2.709.1%
MA20:2.6810.2%
MA50:2.815.0%
MA100:3.146.5%
MA200:3.094.6%
STO9:70.00
STO14:70.00
RSI14:58.82
WPR14:-19.23 
MTM14:0.27
ROC14:0.10 
ATR:0.23 
Week High:3.208.5%
Week Low:2.4122.7%
Month High:3.208.5%
Month Low:2.244.6%
Year High:5.2377.2%
Year Low:2.0146.8%
Volatility:34.49